Barriers to Medication Adherence and Mild Cognitive Impairment Among African Americans with Persistently Uncontrolled Hypertension: A Cross-sectional Analysis from the Southeastern Collaboration Trial - Takeaways - MDSpire

Barriers to Medication Adherence and Mild Cognitive Impairment Among African Americans with Persistently Uncontrolled Hypertension: A Cross-sectional Analysis from the Southeastern Collaboration Trial

  • By

  • Sunidhi Singh

  • Joanna Bryan Ringel

  • Elizabeth Baquero

  • Doyle M. Cummings

  • Jacqueline Halladay

  • Andrea L. Cherrington

  • Lynn Andreae

  • Monika Safford

  • May 4, 2026

  • 0 min

Share

  • 1

    African Americans in the Southeastern US have the highest prevalence of uncontrolled hypertension and associated cognitive impairment.

  • 2

    Barriers to medication adherence may indicate mild cognitive impairment (MCI) in patients with uncontrolled hypertension.

  • 3

    The Southeastern Collaboration Trial assessed the impact of peer coaching and practice facilitation on blood pressure control.

  • 4

    MCI was evaluated using the Six-Item Screener, which effectively identifies cognitive impairment in the trial population.

  • 5

    Addressing medication adherence barriers could lead to earlier identification and management of cognitive decline in hypertensive patients.

Original Source(s)

Related Content